A systematic review of patient–reported outcome measures used in maternal postpartum anxiety

O'Carroll, James; Ando, Kazuo; Yun, Romy; Panelli, Danielle M.; Nicklin, Angela; Kennedy, Norelee; Carvalho, Brendan; Blake, Lindsay; Coker, Jessica L; Kaysen, Debra; Sultan, Pervez

doi:10.1016/j.ajogmf.2023.101076

Cited by 6 publications

(2 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These should not be used for diagnosis or definitive screening for postpartum anxiety or depression. However, the use of patient-reported outcome measures validated for use in the postpartum phase is advocated in future research and quality improvement endeavours to enhance maternal healthcare [7,8]. We agree that future prospective studies should explore the association between poor recovery and iron…”

Section: Quality Of Recovery Following Childbirth: a Multidimensional...mentioning

confidence: 97%

Quality of recovery following childbirth: a multidimensional concept

O'Carroll,

Sultan

2023

Anaesthesia

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Quality Of Recovery Following Childbirth: a Multidimensional...mentioning

confidence: 97%

Quality of recovery following childbirth: a multidimensional concept

O'Carroll,

Sultan

2023

Anaesthesia

Self Cite

View full text Add to dashboard Cite

show abstract

“…The study by James O'Carroll (2023) in his systematic review of patient-reported outcome measures used in maternal postpartum anxiety, evaluated the use of GAD-2 in the postpartum period and concluded that despite having a class A recommendation, it does not fully evaluate the anxiety symptoms in this population. 106 Colombia implemented the GAD-2 in adulthood and old age. 103…”

Section: Phq-2mentioning

confidence: 99%

Mental health screening in patients with type-2 diabetes mellitus

Ropero,

Dallos,

Sandoval

et al. 2023

JDMDC

View full text Add to dashboard Cite

Background: In the world, according to the World Health Organization (WHO), type-2 diabetes mellitus (DM) is very prevalent and causes a serious biological and psychosocial impact, for this reason, it is necessary to avoid its appearance and cardiovascular, metabolic, osteomuscular, joint and mental health complications, the latter has also become a public health problem. Objective: this review article provide knowledge from the social determinants of health and risk factors for mental health in patients with type-2 DM, mental health screening tools and intervention strategies. Methods: The literature search was carried out in Pubmed, Scopus, Google Scholar, Uptodate. Results: It was found that the imbalance in the gut-brain-microbiota axis (MGBA) generates negative consequences on mental health in patients with type-2 DM and should be intervened early through the screening of tools such as the PH4, the DDS, the SRQ, AUDIT, the fagestrom test and the MOCA, which provide information on the state of mental health. Conclusion: It is necessary to screen mental health in patients with type-2 diabetes mellitus with tools that are easy to implement in the outpatient, hospitalization, and institutionalization settings to make an early diagnosis, treatment and avoid the appearance of macro and microvascular complications.

show abstract

Mental health conditions and contraception: current landscape, reproductive health and obstetric outcomes, and clinical guidance

Miller,

Kruger,

Panelli

2024

Current Opinion in Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

Purpose of review This review presents the epidemiology of mental health conditions among reproductive aged people, common adverse reproductive outcomes, the hormonal profile of contraception and its relationship with psychiatric outcomes, and updated information for clinicians providing contraceptive counselling for this population. Recent findings There is variability among contraceptive behaviours and patterns across those who have mental health conditions, impacting reproductive, psychiatric, and perinatal outcomes. The endocrinology of hormonal contraceptives is well understood, however, the impacts of steroidal hormones on mental health outcomes continue to be less understood. Overall, hormonal contraceptives are safe to use among those with mental health conditions, and among those using selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors. Additional considerations are needed when prescribing contraception among people who may be at risk of poor adherence, who use certain classes of antidepressants, antipsychotics, antiepileptics, and who are <6 weeks postpartum. Summary Barriers to effective contraceptive use should be addressed and myths on negative psychiatric impacts of hormonal contraceptives should be dispelled. Healthcare clinicians should seek out opportunities to become proficient in contraception counselling to improve health outcomes among people with mental health conditions.

show abstract

A systematic review of patient–reported outcome measures used in maternal postpartum anxiety

Cited by 6 publications

References 63 publications

Quality of recovery following childbirth: a multidimensional concept

Quality of recovery following childbirth: a multidimensional concept

Mental health screening in patients with type-2 diabetes mellitus

Mental health conditions and contraception: current landscape, reproductive health and obstetric outcomes, and clinical guidance

Contact Info

Product

Resources

About